CARPENTIER-EDWARDS PERIMOUNT PLUS PERICARDIAL BIOPROSTHESIS
Report
- Report Number
- 2015691-2012-18647
- Event Type
- Injury
- Date Received
- November 14, 2012
- Date of Event
- October 10, 2012
- Report Date
- October 15, 2012
- Manufacturer
- EDWARDS LIFESCIENCES
- Product Code
- DYE
- PMA / PMN Number
- P860057/S016
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
ADDITIONAL MANUFACTURER NARRATIVE: THE DHR REVIEW WAS COMPLETED. THIS DEVICE PASSED ALL MANUFACTURING AND STERILIZATION INSPECTIONS WITH NO NONCONFORMANCE.
(B)(4). DEVICE NOT RETURNED. THE DEVICE HISTORY RECORD (DHR) REVIEW IS IN PROGRESS. THROUGH FOLLOW UP WITH THE CUSTOMER, IT WAS LEARNED THE VALVE WILL NOT BE RETURNED FOR EVALUATION DUE TO THE POSSIBLE INFECTION. IT WAS UNKNOWN WHETHER PATHOLOGY TEST WILL BE PERFORMED IN THE HOSPITAL. LATE PROSTHETIC VALVE ENDOCARDITIS, OCCURRING MORE THAN 60 DAYS AFTER SURGERY, IS USUALLY CAUSED BY AN INFECTION WHICH OCCURS ELSEWHERE IN THE BODY, AND THEN SEEDS THE VALVE. THE MOST FREQUENT CAUSES ARE DENTAL PROCEDURES, UROLOGICAL INFECTIONS AND INTERVENTIONS, AND INDWELLING CATHETERS. EDWARDS LIFESCIENCES HAS VALIDATED METHODS FOR STERILIZATION OF ALL DEVICES WHICH ENSURES PRODUCT STERILITY. IN THIS CASE, THE SOURCE AND TYPE OF INFECTION WERE UNKNOWN.
EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL "CUSTOMER COMPLAINT". THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE. IN THIS CASE, A 25MM VALVE WAS EXPLANTED AFTER AN IMPLANT DURATION OF APPROXIMATELY (B)(6) DUE TO MITRAL STENOSIS (MS). THROUGH FOLLOW UP, IT WAS LEARNED THAT ON (B)(6) 2012, THE VALVE WAS EXPLANTED AND REPLACED WITH A MAGNA MITRAL EASE VALVE, MODEL 7300TFX25MM. ON PREOPERATIVE DIAGNOSIS, C-REACTIVE PROTEIN (CRP) LEVEL WAS NORMAL AND IT DID NOT SHOW AN INFLAMMATION REACTION. HOWEVER MRI EXAMINATION SHOWED BLACK DOT IN THE BRAIN WHICH WAS MINUTE CEREBRAL INFARCTION (CI). THE CUSTOMER COMMENTED THAT INFECTIOUS ENDOCARDITIS (IE) WAS SUSPECTED AND CI MIGHT BE CAUSED BY THE VEGETATION. AT EXPLANT, DEGENERATION, WHICH SEEMED TO BE VEGETATION, WAS OBSERVED ON TWO OF THE LEAFLETS. THIS DEGENERATION RESTRICTED MOBILITY IN THE LEAFLETS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CARPENTIER-EDWARDS PERIMOUNT PLUS PERICARDIAL BIOPROSTHESIS | REPLACEMENT HEART VALVE | DYE | EDWARDS LIFESCIENCES | 6900P | 10A008 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR | Hospitalization| R |